1
Journal of NeuroVirology, Volume 6 (2000) and Volume 7 (2001)
Publications by Topic
1. HIV, SIV NeuroAIDS (page 1)
2. HTLV-1 (page 5)
3. HSV (page 6)
4. JCV & PML (page 7)
5. Rabies (page 9)
6. BDV (page 9)
7. Measles (page 10)
8. Influenza, Theiler’s Virus and Coronavirus (page 10)
9. Moloney Murine Leukemia Virus & Other Retroviruses (page 10)
10. Chemokines & Cytokines (page 11)
11. Multiple Sclerosis (page 12)
12. Gene Delivery, Viral Vector (page 15)
13. Other Related Category (page 15)
1. HIV, SIV, Neuro AIDS
Nebuloni M, Pellegrinelli A, Ferri A, Tosoni A, Bonetto S, Zerbi P, Boldorini R, Vago L, Costanzi G.
(2000). Etiology of microglial nodules in brains of patients with acquired immunodeficiency syndrome. J
Neurovirol. 6(1):46-50.
Chong YH, Lee MJ. (2000). Expression of complement inhibitor protein CD59 in human neuronal and glial
cell lines treated with HIV-1 gp41 peptides. J Neurovirol. 6(1):51-60.
Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC. (2000).
Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J
Neurovirol. 6(1):84-8.
Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, Male D, Everall I. (2000). Detection of the
human immunodeficiency virus regulatory protein tat in CNS tissues.
2
J Neurovirol. 6(2):145-55.
Liuzzi GM, Mastroianni CM, Santacroce MP, Fanelli M, D'Agostino C, Vullo V, Riccio P. (2000).
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated
neurological diseases. J Neurovirol. 6(2):156-63.
Smith KM, Crandall KA, Kneissl ML, Navia BA. (2000). PCR detection of host and HIV-1 sequences from
archival brain tissue. J Neurovirol. 6(2):164-71.
Guillemin G, Croitoru J, Le Grand RL, Franck-Duchenne M, Dormont D, Boussin FD. (2000).
Simian immunodeficiency virus mac251 infection of astrocytes. J Neurovirol. 6(3):173-86.
Demuth M, Czub S, Sauer U, Koutsilieri E, Haaft P, Heeney J, Stahl-Hennig C, ter Meulen V, Sopper S.
(2000). Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia
with neurological disease in macaques infected with different strains of SIV.
J Neurovirol. 6(3):187-201.
Huang MB, Weeks O, Zhao LJ, Saltarelli M, Bond VC. (2000). Effects of extracellular human
immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures. J Neurovirol. 6(3):202-20.
Valle LD, Croul S, Morgello S, Amini S, Rappaport J, Khalili K. (2000). Detection of HIV-1 Tat and JCV
capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol.
6(3):221-8.
Hoffmann M, Berger JR, Nath A, Rayens M. (2000). Cerebrovascular disease in young, HIV-infected, black
Africans in the KwaZulu Natal province of South Africa. J Neurovirol. 6(3):229-36.
Boven LA, Middel J, Breij EC, Schotte D, Verhoef J, Soderland C, Nottet HS. (2000).
Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular
endothelial cells result in increased expression of CC chemokines. J Neurovirol. 6(5):382-9.
Brouwers P, Civitello L, DeCarli C, Wolters P, Sei S. (2000). Cerebrospinal fluid viral load is related to
cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease. J
Neurovirol. 6(5):390-7.
Bjugstad KB, Flitter WD, Garland WA, Philpot RM, Kirstein CL, Arendash GW. (2000).
CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha
infusion model for AIDS dementia complex. J Neurovirol. 6(6):478-91.
Chen H, Wood C, Petito CK. (2000). Comparisons of HIV-1 viral sequences in brain, choroid plexus and
spleen: potential role of choroid plexus in the pathogenesis of HIV encephalitis.
J Neurovirol. 6(6):498-506.
Kanmogne GD, Grammas P, Kennedy RC. (2000). Analysis of human endothelial cells and cortical neurons
for susceptibility to HIV-1 infection and co-receptor expression. J Neurovirol. 6(6):519-28
Chen H, Wood C, Petito CK. (2000). Comparisons of HIV-1 viral sequences in brain, choroid plexus and
spleen: potential role of choroid plexus in the pathogenesis of HIV encephalitis.
J Neurovirol. 6(6):498-506.
3
Rostasy K, Monti L, Yiannoutsos C, Wu J, Bell J, Hedreen J, Navia BA. (2000). NFkappaB activation,
TNF-alpha expression, and apoptosis in the AIDS-Dementia-Complex. J Neurovirol. 6(6):537-43
Powderly WG. (2000). Current approaches to treatment for HIV-1 infection. J Neurovirol. 6 Suppl 1:S8S13.
Xiong H, Zeng YC, Lewis T, Zheng J, Persidsky Y, Gendelman HE. (2000) HIV-1 infected mononuclear
phagocyte secretory products affect neuronal physiology leading to cellular demise:
relevance for HIV-1-associated dementia.J Neurovirol. 6 Suppl 1:S14-23.
Gabuzda D, Wang J. (2000). Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis.
J Neurovirol. 6 Suppl 1:S24-32.
Royal W 3rd. (2000). Neurologic disease in injection drug users: therapeutic issues J Neurovirol. 6 Suppl
1:S33-7.
Gray F, Adle-Biassette H, Brion F, Ereau T, le Maner I, Levy V, Corcket G. (2000).
Neuronal apoptosis in human immunodeficiency virus infection. J Neuroviro 6 Suppl 1:S38-43.
Albright AV, Shieh JT, O'Connor MJ, Gonzalez-Scarano F. (2000). Characterization of cultured microglia
that can be infected by HIV-1. J Neurovirol. 6 Suppl 1:S53-60.
Choe W, Albright A, Sulcove J, Jaffer S, Hesselgesser J, Lavi E, Crino P, Kolson DL. (2000).
Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells.
J Neurovirol. 6 Suppl 1:S61-9.
Liu Y, Tang XP, McArthur JC, Scott J, Gartner S. (2000). Analysis of human immunodeficiency virus type
1 gp160 sequences from a patient with HIV dementia: evidence for
monocyte trafficking into brain. J Neurovirol. 6 Suppl 1:S70-81.
Wu DT, Woodman SE, Weiss JM, McManus CM, D'Aversa TG, Hesselgesser J, Major EO, Nath A, Berman
JW. (2000). Mechanisms of leukocyte trafficking into the CNS. J Neurovirol. 6 Suppl 1:S82-5.
Messam CA, Major EO. (2000) Stages of restricted HIV-1 infection in astrocyte cultures derived from
human fetal brain tissue.. J Neurovirol. 6 Suppl 1:S90-4.
Cinque P, Bestetti A, Morelli P, Presi S. (2000). Molecular analysis of cerebrospinal fluid: potential for the
study of HIV-1 infection of the central nervous system. J Neurovirol. 6 Suppl 1:S95-S102.
Everall IP. (2000). Neuronal damage - recent issues and implications for therapy. J Neurovirol. 6 Suppl
1:S103-5.
Perez A, Probert AW, Wang KK, Sharmeen L. (2001). Evaluation of HIV-1 Tat induced neurotoxicity in rat
cortical cell culture. J Neurovirol. 7(1):1-10.
Shieh TM, Carter DL, Blosser RL, Mankowski JL, Zink MC, Clements JE. (2001). Functional analyses of
natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J Neurovirol.
2001 Feb;7(1):11-24.
Kohleisen B, Hutzler P, Shumay E, Ovod V, Erfle V. (2001). HIV-1 Nef co-localizes with the astrocytespecific cytoskeleton protein GFAP in persistently nef-expressing human astrocytes.
4
J Neurovirol. 2001 Feb;7(1):52-5.
Smith DG, Guillemin GJ, Pemberton L, Kerr S, Nath A, Smythe GA, Brew BJ. (2001).
Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J
Neurovirol. 7(1):56-60.
Levin MC, Rosenblum MK, Fox CH, Jacobson S. (2001). Localization of retrovirus in the central nervous
system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia. J
Neurovirol. 7(1):61-5.
Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR. (2001). Acceleration of HIV dementia with
methamphetamine and cocaine. J Neurovirol. 7(1):66-71.
Stins MF, Shen Y, Huang SH, Gilles F, Kalra VK, Kim KS. (2001) Gp120 activates children's brain
endothelial cells via CD4. J Neurovirol. 7(2):125-34.
Schweighardt B, Shieh JT, Atwood WJ. (2001). CD4/CXCR4-independent infection of human astrocytes by
a T-tropic strain of HIV-1. J Neurovirol. 7(2):155-62.
Piller SC. (2001). Effect of extracellular HIV-1 Vpr protein in vitro. J Neurovirol. 7(2):183-5. No abstract
available.
Schweighardt B, Atwood WJ. (2001). Virus receptors in the human central nervous system. J Neurovirol.
7(3):187-95. Review.
Albright AV, Martin J, O'Connor M, Gonzalez-Scarano F. (2001). Interactions between HIV-1 gp120,
chemokines, and cultured adult microglial cells. J Neurovirol. 7(3):196-207.
Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B. (2001).
HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced
C/EBP factor binding and increased LTR-specific activity. J Neurovirol. 7(3):235-49.
Shieh TM, Carter DL, Blosser RL, Mankowski JL, Zink MC, Clements JE. (2001). Functional analyses of
natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J Neurovirol.
2001 Feb;7(1):11-24.
Albright AV, Martin J, O'Connor M, Gonzalez-Scarano F. (2001). Interactions between HIV-1 gp120,
chemokines, and cultured adult microglial cells. J Neurovirol. 7(3):196-207.
Antinori A, Ammassari A, Giancola ML, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F,
Larussa D, Ippolito G, De Luca A. (2001). Epidemiology and prognosis of AIDS-associated progressive
multifocal leukoencephalopathy in the HAART era. J Neurovirol. 7(4):323-8.
Berger JR, Chauhan A, Galey D, Nath A. (2001). Epidemiological evidence and molecular basis of
interactions between HIV and JC virus. J Neurovirol. 7(4):329-38.
Geschwind M, Skolasky R, Royal W, McArthur J. (2001). The relative contributions of HAART and alphainterferon for therapy of progressive multifocal leukoencephalopathy in AIDS J Neurovirol. 7(4):353-7.
Cinque P, Pierotti C, Vigano MG, Bestetti A, Fausti C, Bertelli D, Lazzarin A. (2001). The good and evil of
HAART in HIV-related progressive multifocal leukoencephalopathy.
5
J Neurovirol. 7(4):358-63.
De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G,
Cauda R, Monforte A, Antinori A. (2001). Potent anti-retroviral therapy with or without cidofovir for AIDSassociated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study. J
Neurovirol. 7(4):364-8.
Gasnault J, Kousignian P, Kahraman M, Rahoiljaon J, Matheron S, Delfraissy JF, Taoufik Y. (2001).
Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: A monocenter observational
study with clinical and JC virus load monitoring. J Neurovirol. 7(4):375-81.
Levy RM, Major E, Ali MJ, Cohen B, Groothius D. (2001) Convection-enhanced intraparenchymal delivery
(CEID) of cytosine arabinoside (AraC) for the treatment of
HIV-related progressive multifocal leukoencephalopathy (PML). J Neurovirol. 7(4):382-5.
Aksamit A. (2001). Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine
arabinoside. J Neurovirol. 7(4):386-90.
Andersson L, Hagberg L, Fuchs D, Svennerholm B, Gisslen M. (2001) Increased blood-brain barrier
permeability in neuro-asymptomatic HIV-1-infected individuals-correlation with cerebrospinal fluid HIV-1
RNA and neopterin levels. J Neurovirol Dec;7(6):542-547.
Sung JH, Shin SA, Park HK, Montelaro RC, Chong YH. (2001). Protective effect of glutathione in HIV-1
lytic peptide 1-induced cell death in human neuronal cells. J Neurovirol. Oct;7(5):454-65.
Lokensgard JR, Hu S, Hegg CC, Thayer SA, Gekker G, Peterson PK. (2001). Diazepam inhibits HIV-1 Tatinduced migration of human microglia. J Neurovirol. Oct;7(5):481-6.
Nakagaki K, Nakagaki K, Takahashi K, Schols D, De Clercq E, Tabira T. (2001). CXCR4 is the primary
receptor for feline immunodeficiency virus in astrocytes.
J Neurovirol. Oct;7(5):487-92.
Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, Richardson MW, Amini S,
Morgello S, Khalili K, Rappaport J. (2001). CNS invasion by CD14+/CD16+ peripheral blood-derived
monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol.
Dec;7(6):528-541.
2. HTLV-l
Nakane S, Shirabe S, Moriuchi R, Mizokami A, Furuya T, Nishiura Y, Okazaki S, Yoshizuka N,
Suzuki Y, Nakamura T, Katamine S, Gojobori T, Eguchi K. (2000). Comparative molecular analysis of
HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant
HTLV-I-associated myelopathy in monozygotic twins. J Neurovirol. 6(4):275-83.
Danaher RJ, Jacob RJ, Miller CS. (2000). Herpesvirus quiescence in neuronal cells: antiviral conditions not
required to establish and maintain HSV-2 quiescence. J Neurovirol. 6(4):296-302.
Szymocha R, Brisson C, Bernard A, Akaoka H, Belin MF, Giraudon P. (2000) Long-term effects of HTLV1 on brain astrocytes: sustained expression of Tax-1 associated with synthesis of inflammatory mediators. J
Neurovirol. 6(4):350-7.
6
Matsuzaki T, Nakagawa M, Nagai M, Nobuhara Y, Usuku K, Higuchi I, Takahashi K, Moritoyo T, Arimura
K, Izumo S, Akiba S, Osame M. (2000). HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis
(TSP) with amyotrophic lateral sclerosis-like manifestations.
J Neurovirol. 6(6):544-8.
Levin MC, Rosenblum MK, Fox CH, Jacobson S. (2001). Localization of retrovirus in the central nervous
system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia. J
Neurovirol. 7(1):61-5.
Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, Kubota H, Izumo S, Akiba S, Osame
M. (2001). HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of
239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol. 7(3):228-34.
3. HSV
Millhouse S, Wigdahl B. (2000). Molecular circuitry regulating herpes simplex virus type 1 latency in
neurons. J Neurovirol. 6(1): 6-24. Review.
Thompson KA, Blessing WW, Wesselingh SL. (2000). Herpes simplex replication and dissemination is not
increased by corticosteroid treatment in a rat model of focal Herpes
encephalitis. J Neurovirol. 6(1): 25-32.
Holmes KD, Cassam AK, Chan B, Peters AA, Weaver LC, Dekaban GA. (2000). A multi-mutant herpes
simplex virus vector has minimal cytotoxic effects on the distribution of filamentous actin, alpha-actinin 2
and a glutamate receptor in differentiated PC12 cells. J Neurovirol. 6(1): 33-45.
Chowdhury SI, Lee BJ, Onderci M, Weiss ML, Mosier D. (2000). Neurovirulence of glycoprotein C(gC)deleted bovine herpesvirus type-5 (BHV-5) and BHV-5 expressing BHV-1
gC in a rabbit seizure model. J Neurovirol. 6(4):284-95.
Danaher RJ, Jacob RJ, Miller CS. (2000). Herpesvirus quiescence in neuronal cells: antiviral conditions not
required to establish and maintain HSV-2 quiescence. J Neurovirol. 6(4):296-302.
Boggian I, Buzzacaro E, Calistri A, Calvi P, Cavaggioni A, Mucignat-Caretta C, Palu G. (2000).
Asymptomatic herpes simplex type 1 virus infection of the mouse brain. J Neurovirol. 6(4):303-13.
Fukushi H, Taniguchi A, Yasuda K, Yanai T, Masegi T, Yamaguchi T, Hirai K. (2000). A hamster model
of equine herpesvirus 9 induced encephalitis. J Neurovirol. 6(4):314-9.
Su YH, Moxley M, Kejariwal R, Mehta A, Fraser NW, Block TM. (2000). The HSV 1 genome in
quiescently infected NGF differentiated PC12 cells can not be stimulated by HSV
superinfection. J Neurovirol. 6(4):341-9.
Yamamoto T, Nakamura Y. (2000). A single tube PCR assay for simultaneous amplification of HSV-1/-2,
VZV, CMV, HHV-6A/-6B, and EBV DNAs in cerebrospinal fluid from patients with virus-related
neurological diseases. J Neurovirol. 6(5):410-7.
Weir JP. (2001). Infection of human NT2 cells and differentiated NT-neurons with herpes simplex virus and
replication-incompetent herpes simplex virus vectors. J Neurovirol. 7(1):43-51
7
Marques AR, Straus SE, Fahle G, Weir S, Csako G, Fischer SH. (2001). Lack of association between HSV-1
DNA in the brain, Alzheimer's disease and apolipoprotein E4. J Neurovirol. 7(1):82-3.
Thomas HC, Kapadia RD, Wells GI, Gresham AM, Sutton D, Solleveld HA, Sarkar SK, Dillon SB, TalSinger R. (2001). Differences in pathogenicity of herpes simplex virus serotypes 1 and 2 may be observed
by histopathology and high-resolution magnetic resonance imaging in a murine encephalitis model. J
Neurovirol. 7(2):105-16.
Cheeran MC, Hu S, Yager SL, Gekker G, Peterson PK, Lokensgard JR. (2001). Cytomegalovirus induces
cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications. J
Neurovirol. 7(2):135-47
Springer SL, Vite CH, Polesky AC, Kesari S, Fraser NW, Wolfe JH. (2001). Infection and establishment of
latency in the dog brain after direct inoculation of a nonpathogenic strain of herpes simplex virus-1. J
Neurovirol. 7(2):149-54.
Danaher RJ, Savells-Arb AD, Black SA Jr, Jacob RJ, Miller CS. (2001). Herpesvirus quiescence in
neuronal cells IV: virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP)
involves the protein kinase A pathway. J Neurovirol. 7(2):163-8.
Lokensgard JR, Hu S, Sheng W, vanOijen M, Cox D, Cheeran MC, Peterson PK. (2001).
Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during
nonproductive infection with herpes simplex virus. J Neurovirol. 7(3):208-19.
Tang J, Yang T, Ghosh HP, Geller AI. (2001) Helper virus-free HSV-1 vectors packaged both in the
presence of VSV G protein and in the absence of HSV-1 glycoprotein B support gene transfer into neurons in
the rat striatum. J Neurovirol. Dec;7(6):548-555.
Alonso M, Dimitrijevic A, Recuero M, Serrano E, Valdivieso F, Lopez-Guerrero JA. (2001) Interaction of
alpha-2-macroglobulin and HSV-1 during infection of neuronal cells. J Neurovirol. Dec;7(6):556-563.
Tomsone V, Logina I, Millers A, Chapenko S, Kozireva S, Murovska M. (2001) Association of human
herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system. J Neurovirol.
Dec;7(6):564-569.
Itzhaki RF, Dobson CB, Lin WR, Wozniak MA (2001). Association of HSV1 and apolipoprotein Evarepsilon4 in Alzheimer's disease. J Neurovirol. Dec;7(6):570-571.
4. JCV & PML
Wei G, Liu CK, Atwood WJ. (2000) JC virus binds to primary human glial cells, tonsillar stromal cells, and
B-lymphocytes, but not to T lymphocytes. J Neurovirol. 6(2):127-36.
Valle LD, Croul S, Morgello S, Amini S, Rappaport J, Khalili K. (2000). Detection of HIV-1 Tat and JCV
capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol.
6(3):221-8.
Boven LA, Middel J, Breij EC, Schotte D, Verhoef J, Soderland C, Nottet HS. (2000).
Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular
endothelial cells result in increased expression of CC chemokines. J Neurovirol. 6(5):382-9.
8
Vaz B, Cinque P, Pickhardt M, Weber T. (2000). Analysis of the transcriptional control region in
progressive multifocal leukoencephalopathy. J Neurovirol. 6(5):398-409.
Ferrante P, Mediati M, Caldarelli-Stefano R, Losciale L, Mancuso R, Cagni AE, Maserati R. (2001).
Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive
multifocal leukoencephalopathy patients. J Neurovirol. 7(1):35-42.
Prins C, Frisque RJ. (2001). JC virus T' proteins encoded by alternatively spliced early mRNAs enhance T
antigen-mediated viral DNA replication in human cells. J Neurovirol. 7(3):250-64.
Clifford DB, Major EO. (2001). The biology of JC virus and progressive multifocal leukoencephalopathy. J
Neurovirol. 2001 Aug;7(4):279.
Jensen PN, Major EO. (2001). A classification scheme for human polyomavirus JCV variants based on the
nucleotide sequence of the noncoding regulatory region. J Neurovirol. 7(4):280-7.
Safak M, Khalili K. (2001). Physical and functional interaction between viral and cellular proteins modulate
JCV gene transcription. J Neurovirol. 7(4):288-92.
Frisque RJ. (2001). Structure and function of JC virus T' proteins. J Neurovirol. 7(4):293-7.
Ou WC, Chen LH, Wang M, Hseu TH, Chang D. (2001). Analysis of minimal sequences on JC virus VP1
required for capsid assembly. J Neurovirol. 7(4):298-301.
Okada Y, Endo S, Takahashi H, Sawa H, Umemura T, Nagashima K. (2001). Distribution and function of
JCV agnoprotein. J Neurovirol. 7(4):302-6.
Atwood WJ. (2001). A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the
spread of JC virus (JCV) in a tissue culture model: Implications for prophylactic and therapeutic treatment of
progressive multifocal leukencephalopathy. J Neurovirol. 7(4):307-10.
Weber T, Weber F, Petry H, Luke W. (2001). Immune response in progressive multifocal
leukoencephalopathy: An overview. J Neurovirol. 7(4):311-7.
Du Pasquier RA, Clark KW, Smith PS, Joseph JT, Mazullo JM, De Girolami U, Letvin NL, Koralnik IJ.
(2001). JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected
individuals with progressive multifocal leukoencephalopathy J Neurovirol. 7(4):318-22.
Antinori A, Ammassari A, Giancola ML, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F,
Larussa D, Ippolito G, De Luca A. (2001). Epidemiology and prognosis of AIDS-associated progressive
multifocal leukoencephalopathy in the HAART era. J Neurovirol. 7(4):323-8.
Berger JR, Chauhan A, Galey D, Nath A. (2001). Epidemiological evidence and molecular basis of
interactions between HIV and JC virus. J Neurovirol. 7(4):329-38.
Cubitt CL, Cui X, Agostini HT, Nerurkar VR, Scheirich I, Yanagihara R, Ryschkewitsch CF, Stoner GL.
(2001). Predicted amino acid sequences for 100 JCV strains. J Neurovirol. 7(4):339-44.
Bofill-Mas S, Girones R. (2001). Excretion and transmission of JCV in human populations.
J Neurovirol. 7(4):345-9.
9
Clifford DB. (2001). Challenges for clinical trials on progressive multifocal leukoencephalopathy. J
Neurovirol. 2001 Aug;7(4):350-2.
Geschwind M, Skolasky R, Royal W, McArthur J. (2001). The relative contributions of HAART and alphainterferon for therapy of progressive multifocal leukoencephalopathy in AIDS
J Neurovirol. 7(4):353-7.
Cinque P, Pierotti C, Vigano MG, Bestetti A, Fausti C, Bertelli D, Lazzarin A. (2001). The good and evil of
HAART in HIV-related progressive multifocal leukoencephalopathy.
J Neurovirol. 7(4):358-63.
De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G,
Cauda R, Monforte A, Antinori A. (2001). Potent anti-retroviral therapy with or without cidofovir for AIDSassociated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study. J
Neurovirol. 7(4):364-8.
Yiannoutsos CT, De Luca A. (2001). Designs for clinical trials to test the efficacy of therapeutics in
progressive multifocal leukoencephalopathy. J Neurovirol. 7(4):369-74.
Gasnault J, Kousignian P, Kahraman M, Rahoiljaon J, Matheron S, Delfraissy JF, Taoufik Y. (2001).
Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: A monocenter observational
study with clinical and JC virus load monitoring. J Neurovirol. 7(4):375-81.
Levy RM, Major E, Ali MJ, Cohen B, Groothius D. (2001) Convection-enhanced intraparenchymal delivery
(CEID) of cytosine arabinoside (AraC) for the treatment of
HIV-related progressive multifocal leukoencephalopathy (PML). J Neurovirol. 7(4):382-5.
Aksamit A. (2001). Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine
arabinoside. J Neurovirol. 7(4):386-90.
Andersson L, Hagberg L, Fuchs D, Svennerholm B, Gisslen M. (2001) Increased blood-brain barrier
permeability in neuro-asymptomatic HIV-1-infected individuals-correlation with cerebrospinal fluid HIV-1
RNA and neopterin levels. J Neurovirol Dec;7(6):542-547.
5. Rabies
Galelli A, Baloul L, Lafon M. (2000). Abortive rabies virus central nervous infection is controlled by T
lymphocyte local recruitment and induction of apoptosis. J Neurovirol. 6(5):359-72.
Morimoto K, Foley HD, McGettigan JP, Schnell MJ, Dietzschold B. (2000). Reinvestigation of the role of
the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach.
J Neurovirol. 6(5):373-81.
Camelo S, Lafage M, Lafon M. (2000). Absence of the p55 Kd TNF-alpha receptor promotes survival in
rabies virus acute encephalitis. J Neurovirol. 6(6):507-18.
Reid JE, Jackson AC. (2001). Experimental rabies virus infection in Artibeus jamaicensis bats with CVS-24
variants. J Neurovirol. Dec;7(6):511-517.
10
Yan X, Prosniak M, Curtis MT, Weiss ML, Faber M, Dietzschold B, Fu ZF. (2001). Silver-haired bat rabies
virus variant does not induce apoptosis in the brain of experimentally infected mice. J Neurovirol.
Dec;7(6):518-527
6. BDV
Zocher M, Czub S, Schulte-Monting J, de La Torre JC, Sauder C. (2000). Alterations in neurotrophin and
neurotrophin receptor gene expression patterns in the rat central nervous system following perinatal Borna
disease virus infection. J Neurovirol. 6(6):462-77.
Enbergs HK, Vahlenkamp TW, Kipar A, Muller H. (2001). Experimental infection of mice with Borna
disease virus (BDV): replication and distribution of the virus after intracerebral infection.
J Neurovirol. 7(3):272-7
7. Measles
Hara T, Yamashita S, Aiba H, Nihei K, Koide N, Good RA, Takeshita K. (2000). Measles virus-specific T
helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol. 6(2):121-6.
Fang YY, Son ZM, Dhib-Jalbut S. (2001). Mechanism of measles virus failure to activate NF-kappaB in
neuronal cells. J Neurovirol. 7(1):25-34.
8. INFLUENZA, THEILER’S VIRUS AND CORONAVIRUS
Murray PD, Krivacic K, Chernosky A, Wei T, Ransohoff RM, Rodriguez M. (2000). Biphasic and
regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of
multiple sclerosis. J Neurovirol. 6 Suppl 1:S44-52.
Davis LE, Kornfeld M, Daniels RS, Skehel JJ. (2000). Experimental influenza causes a non-permissive viral
infection of brain, liver and muscle. J Neurovirol. 6(6):529-36.
Aronsson F, Karlsson H, Ljunggren HG, Kristensson K. (2001). Persistence of the influenza A/WSN/33
virus RNA at midbrain levels of immunodefective mice. J Neurovirol 7(2):117-24.
Libbey JE, McCright IJ, Tsunoda I, Wada Y, Fujinami RS. (2001). Peripheral nerve protein, P0, as a
potential receptor for Theiler's murine encephalomyelitis virus. J Neurovirol. 7(2):97-104.
Theil DJ, Tsunoda I, Rodriguez F, Whitton JL, Fujinami RS. (2001). Viruses can silently prime for and
trigger central nervous system autoimmune disease. J Neurovirol.7(3):220-7.
Begolka WS, Haynes LM, Olson JK, Padilla J, Neville KL, Canto MD, Palma J, Kim BS, Miller SD. (2001).
CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased
demyelinating pathology. J Neurovirol. Oct;7(5):409-20.
Phillips JJ, Chua M, Seo Sh, Weiss SR. (2001). Multiple regions of the murine coronavirus spike
glycoprotein influence neurovirulence. J Neurovirol Oct;7(5):421-31.
11
Sarma JD, Fu L, Hingley ST, Lai MM, Lavi E. (2001). Sequence analysis of the S gene of recombinant
MHV-2/A59 coronaviruses reveals three candidate mutations associated with demyelination and hepatitis. J
Neurovirol Oct;7(5):432-6.
9. MOLONEY MURINE LEUKEMIA VIRUS AND
OTHER RETROVIRUSES
Afanasieva TA, Pekarik V, Grazia D'Angelo M, Klein MA, Voigtlander T, Stocking C,
Aguzzi A. (2001). Insertional mutagenesis of preneoplastic astrocytes by Moloney murine leukemia virus. J
Neurovirol. 7(2):169-81.
Kim HT, Qiang W, Wong PK, Stoica G. (2001). Enhanced proteolysis of IkappaBalpha and IkappaBbeta
proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: A potential mechanism
of NF-kappaB activation. J Neurovirol. Oct;7(5):466-75.
Hansen R, Sauder C, Czub S, Bachmann E, Schimmer S, Hegyi A, Czub M. (2001). Activation of microglia
cells is dispensable for the induction of rat retroviral spongiform encephalopathy.
J Neurovirol. Dec;7(6):501-510.
10. CHEMOKINES AND CYTOKINES
Bjugstad KB, Flitter WD, Garland WA, Philpot RM, Kirstein CL, Arendash GW. (2000).
CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha
infusion model for AIDS dementia complex. J Neurovirol. 6(6):478-91.
Camelo S, Lafage M, Lafon M. (2000). Absence of the p55 Kd TNF-alpha receptor promotes survival in
rabies virus acute encephalitis. J Neurovirol. 6(6):507-18.
Rostasy K, Monti L, Yiannoutsos C, Wu J, Bell J, Hedreen J, Navia BA. (2000). NFkappaB activation,
TNF-alpha expression, and apoptosis in the AIDS-Dementia-Complex. J Neurovirol. 6(6):537-43
Gabuzda D, Wang J. (2000). Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis.
J Neurovirol. 6 Suppl 1:S24-32.
Murray PD, Krivacic K, Chernosky A, Wei T, Ransohoff RM, Rodriguez M. (2000). Biphasic and
regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of
multiple sclerosis. J Neurovirol. 6 Suppl 1:S44-52.
Schweighardt B, Shieh JT, Atwood WJ. (2001). CD4/CXCR4-independent infection of human astrocytes by
a T-tropic strain of HIV-1. J Neurovirol. 7(2):155-62.
Cheeran MC, Hu S, Yager SL, Gekker G, Peterson PK, Lokensgard JR. (2001). Cytomegalovirus induces
cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications. J
Neurovirol. 7(2):135-47
Schweighardt B, Atwood WJ. (2001). Virus receptors in the human central nervous system. J Neurovirol.
7(3):187-95. Review.
Lokensgard JR, Hu S, Sheng W, vanOijen M, Cox D, Cheeran MC, Peterson PK. (2001).
12
Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during
nonproductive infection with herpes simplex virus. J Neurovirol. 7(3):208-19.
Albright AV, Martin J, O'Connor M, Gonzalez-Scarano F. (2001). Interactions between HIV-1 gp120,
chemokines, and cultured adult microglial cells. J Neurovirol. 7(3):196-207.
Karpus WJ. (2001). Chemokines and central nervous system disorders. J Neurovirol. Dec;7(6):493-500.
Nakagaki K, Nakagaki K, Takahashi K, Schols D, De Clercq E, Tabira T. (2001). CXCR4 is the primary
receptor for feline immunodeficiency virus in astrocytes.
J Neurovirol. Oct;7(5):487-92.
11. MULTIPLE SCLEROSIS
Ferrante P. (2000) The puzzling natural history of multiple sclerosis: a challenge for the research and care. J
Neurovirol. 6 Suppl 2:S1-3. Review.
Murray PD, Krivacic K, Chernosky A, Wei T, Ransohoff RM, Rodriguez M. (2000). Biphasic and
regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of
multiple sclerosis. J Neurovirol. 6 Suppl 1:S44-52.
Cazzullo CL. (2000). History and activities of the Don Carlo Gnocchi multiple sclerosis center. J
Neurovirol. 6 Suppl 2:S4.
Compston A. (2000). The genetics of multiple sclerosis. J Neurovirol. 6 Suppl 2:S5-9.
Oksenberg JR, Barcellos LF. (2000). The complex genetic aetiology of multiple sclerosis.
J Neurovirol. 6 Suppl 2:S10-4.
Hillert J. (2000). MS genetics: recent Scandinavian efforts. J Neurovirol. 6 Suppl 2:S15-7.
D'Alfonso S, Nistico L, Bocchio D, Bomprezzi R, Marrosu MG, Murru MR, Lai M, Massacesi L, Ballerini
C, Repice A, Salvetti M, Montesperelli C, Ristori G, Trojano M, Liguori M, Gambi D, Quattrone A, Tosi R,
Momigliano-Richiardi P. (2000). An attempt of identifying MS-associated loci as a follow-up of a genomic
linkage study in the Italian population. J Neurovirol. 6 Suppl 2:S18-22.
Rasmussen HB, Clausen J. (2000). Genetic risk factors in multiple sclerosis and approaches to their
identification. J Neurovirol. 6 Suppl 2:S23-7.
Guerini FR, Losciale L, Mediati M, Speciale L, Mancuso R, Saresella M, Calvo MG, Caputo D, Ferrante P.
(2000). A polymorphism in the repetitive (TGGA)n sequence 5' to the human myelin basic protein gene in
Italian multiple sclerosis patients. J Neurovirol. 6 Suppl 2:S28-32.
Sciacca FL, Canal N, Edoardo Grimaldi LM. (2000). Induction of IL-1 receptor antagonist by interferon
beta: implication for the treatment of multiple sclerosis. J Neurovirol. 6 Suppl 2:S33-7.
Trabattoni D, Ferrante P, Fusi ML, Saresella M, Caputo D, Urnovitz H, Cazzullo CL, Clerici M. (2000).
Augmented type 1 cytokines and human endogenous retroviruses specific immune responses in patients with
acute multiple sclerosis. J Neurovirol. 6 Suppl 2:S38-41.
13
Pinter C, Beltrami S, Caputo D, Ferrante P, Clivio A. (2000). Presence of autoantibodies against
complement regulatory proteins in relapsing-remitting multiple sclerosis. J Neurovirol. 6 Suppl 2:S42-6.
Trojano M, Defazio G, Avolio C, Paolicelli D, Giuliani F, Giorelli M, Livrea P. (2000). Effects of rIFNbeta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound
ICAM-1 expression on brain microvascular endothelial cells. J Neurovirol. 6 Suppl 2:S47-51.
Uccelli A, Ristori G, Giunti D, Seri M, Montesperelli C, Caroli F, Solaro C, Murialdo A, Marchese M,
Buttinelli C, Mancardi G, Salvetti M. (2000). Dynamics of the reactivity to MBP in multiple sclerosis. J
Neurovirol. 6 Suppl 2:S52-6.
Speciale L, Saresella M, Caputo D, Ruzzante S, Mancuso R, Calvo MG, Guerini FR, Ferrante P.
(2000). Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b.
J Neurovirol. 6 Suppl 2:S57-61.
Speciale L, Sarasella M, Ruzzante S, Caputo D, Mancuso R, Calvo MG, Guerini FR, Ferrante P. (2000).
Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurovirol. 6
Suppl 2:S62-6.
Perron H, Perin JP, Rieger F, Alliel PM. (2000). Particle-associated retroviral RNA and tandem
RGH/HERV-W copies on human chromosome 7q: possible components of a 'chain-reaction' triggered by
infectious agents in multiple sclerosis? J Neurovirol. 6 Suppl 2:S67-75.
Haahr S, Munch M. (2000). The association between multiple sclerosis and infection with Epstein-Barr
virus and retrovirus. J Neurovirol. 6 Suppl 2:S76-9.
Rasmussen HB, Lucotte G, Clausen J. (2000). Endogenous retroviruses and multiple sclerosis. J
Neurovirol. 6 Suppl 2:S80-4.
Berti R, Soldan SS, Akhyani N, McFarland HF, Jacobson S. (2000). Extended observations on the
association of HHV-6 and multiple sclerosis. J Neurovirol. 6 Suppl 2:S85-7.
Rotola A, Caselli E, Cassai E, Tola MR, Granieri E, Luca DD. (2000). Novel human herpesviruses and
multiple sclerosis. J Neurovirol. 6 Suppl 2:S88-91.
Gordon J, Gallia GL, Valle LD, Amini S, Khalili K. (2000). Human polyomavirus JCV and expression of
myelin genes. J Neurovirol. 6 Suppl 2:S92-7.
Hou J, Major EO.(2000). Progressive multifocal leukoencephalopathy: JC virus induced demyelination in
the immune compromised host. J Neurovirol. 6 Suppl 2:S98-S100.
Agostini HT, Ryschkewitsch CF, Baumhefner RW, Tourtellotte WW, Singer EJ, Komoly S, Stoner GL.
(2000). Influence of JC virus coding region genotype on risk of multiple sclerosis and progressive
multifocal leukoencephalopathy. J Neurovirol. 6 Suppl 2:S101-8.
Ferrante P, Mancuso R, Pagani E, Guerini FR, Calvo MG, Saresella M, Speciale L, Caputo D. (2000).
Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack.
J Neurovirol. ;6 Suppl 2:S109-14.
14
Filippi M, Rovaris M. (2000). Magnetisation transfer imaging in multiple sclerosis J Neurovirol. 2000
May;6 Suppl 2:S115-20.
Stefano ND, Narayanan S, Matthews PM, Mortilla M, Dotti MT, Federico A, Arnold DL. (2000). Proton
MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders. J
Neurovirol. 6 Suppl 2:S121-9.
Bastianello S, Paolillo A, Giugni E, Giuliani S, Evangelisti G, Luccichenti G, Angeloni U, Colonnese C,
Salvetti, M, Gasperini C, Pozzilli C, Fieschi C. (2000). MRI of spinal cord in MS.
J Neurovirol. 6 Suppl 2:S130-3.
Kurtzke JF. (2000). Multiple sclerosis in time and space--geographic clues to cause.
J Neurovirol. 6 Suppl 2:S134-40.
Granieri E. (2000). Exogeneous factors in the aetiology of multiple sclerosis. J Neurovirol. 6 Suppl 2:S1416
Casetta I, Granieri E. (2000). Clinical infections and multiple sclerosis: contribution from analytical
epidemiology. J Neurovirol. 6 Suppl 2:S147-51. Review.
Boiko AN, Guseva ME, Guseva MR, Boiko SY, Sudomoina MA, Bikova OV, Maslova OI, Favorova OO,
Gusev EI. (2000). Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children.
J Neurovirol. 6 Suppl 2:S152-5.
Alpini D, Caputo D, Hahan A, Pugnetti L, Monti B, Razzari S, Cesarani A. (2000). Grading brainstem
involvement in multiple sclerosis - by means of electro-oculography. J Neurovirol. 6 Suppl 2:S156-9.
Minden SL. (2000). Mood disorders in multiple sclerosis: diagnosis and treatment. J Neurovirol. 2000
May;6 Suppl 2:S160-7.
Landoni MG, Giordano MT, Guidetti GP. (2000). Group psychotherapy experiences for people with
multiple sclerosis and psychological support for families. J Neurovirol. 2000 May;6 Suppl 2:S168-71.
Rovaris M, Filippi M. (2000). MRI correlates of cognitive dysfunction in multiple sclerosis patients. J
Neurovirol. 6 Suppl 2:S172-5.
Westarp ME. (2000). Medical rehabilitation of chronic progressive disseminated encephalomyelitis (MS). J
Neurovirol. 6 Suppl 2:S176-8.
Cardini RG, Crippa AC, Cattaneo D. (2000). Update on multiple sclerosis rehabilitation.
J Neurovirol. 6 Suppl 2:S179-85.
Cutajar R, Ferriani E, Scandellari C, Sabattini L, Trocino C, Marchello LP, Stecchi S. (2000).
Cognitive function and quality of life in multiple sclerosis patients. J Neurovirol. 6 Suppl 2:S186-90.
Battaglia MA, Zagami P, Uccelli MM. (2000). A cost evaluation of multiple sclerosis.
J Neurovirol. 6 Suppl 2:S191-3.
12. GENE DELIVERY, VIRAL VECTOR
15
Rubio N, Abad-Rodriguez J. (2001). Adenovirus vector-directed expression of the neurotrophin-3 receptor
(TrkC) in mouse astrocytes. J Neurovirol. 7(1):72-81.
Keir SD, Xiao X, Li J, Kennedy PG. (2001). Adeno-associated virus-mediated delivery of glial cell linederived neurotrophic factor protects motor neuron-like cells from apoptosis.
J Neurovirol. Oct;7(5):437-46.
13. OTHER RELATED CATEGORY
Schlenker EH, Jones QA, Rowland RR, Steffen-Bien M, Cafruny WA. (2001). Age-dependent poliomyelitis
in mice is associated with respiratory failure and viral replication in the central nervous system and lung. J
Neurovirol. 7(3):265-71
Bencsik A, Lezmi S, Baron T. (2001) Autonomous nervous system innervation of lymphoid territories in
spleen: A possible involvement of noradrenergic neurons for prion neuroinvasion in natural scrapie. J
Neurovirol. Oct;7(5):447-53.
Mata M, Zhang M, Hu X, Fink DJ. (2001). HveC (nectin-1) is expressed at high levels in sensory neurons,
but not in motor neurons, of the rat peripheral nervous system. J Neurovirol. Oct;7(5):476-8
Perry VH. (2000). Persistent pathogens in the parenchyma of the brain. J Neurovirol. 6 Suppl 1:S86-9